Pharmacogenomics of cisplatin‐induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy
Abstract Purpose Cisplatin is a critical component of first‐line chemotherapy for several cancers, but causes peripheral sensory neuropathy, hearing loss, and tinnitus. We aimed to identify comorbidities for cisplatin‐induced neurotoxicities among large numbers of similarly treated patients without...
Asıl Yazarlar: | Xindi Zhang, Matthew R. Trendowski, Emma Wilkinson, Mohammad Shahbazi, Paul C. Dinh, Megan M. Shuey, Regeneron Genetics Center, Darren R. Feldman, Robert J. Hamilton, David J. Vaughn, Chunkit Fung, Christian Kollmannsberger, Robert Huddart, Neil E. Martin, Victoria A. Sanchez, Robert D. Frisina, Lawrence H. Einhorn, Nancy J. Cox, Lois B. Travis, M. Eileen Dolan |
---|---|
Materyal Türü: | Makale |
Dil: | English |
Baskı/Yayın Bilgisi: |
Wiley
2022-07-01
|
Seri Bilgileri: | Cancer Medicine |
Konular: | |
Online Erişim: | https://doi.org/10.1002/cam4.4644 |
Benzer Materyaller
-
Comprehensive association analysis of speech recognition thresholds after cisplatin‐based chemotherapy in survivors of adult‐onset cancer
Yazar:: Mohammad Shahbazi, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01) -
Association of hearing loss and tinnitus symptoms with health‐related quality of life among long‐term oropharyngeal cancer survivors
Yazar:: Puja Aggarwal, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01) -
Development of Tinnitus and Hyperacusis in a Mouse Model of Tobramycin Cochleotoxicity
Yazar:: Ryan J. Longenecker, ve diğerleri
Baskı/Yayın Bilgisi: (2021-09-01) -
Comparison of GWAS results between de novo tinnitus and cancer treatment-related tinnitus suggests distinctive roles for genetic risk factors
Yazar:: Mohammad Shahbazi, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01) -
Topical gentamicin-induced acute vestibulopathy: A case report
Yazar:: Teik Beng Lau, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)